January 30, 2019
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer’s Prevenar 13™Vaccine
Read More
December 10, 2018
Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose
Read More
December 10, 2018
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Read More
X